ALBO Gross Margin

The Gross Margin of Albireo Pharma Inc (ALBO) is 96.66%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ALBO Gross Margin - Historical Value

Date	Value
2021-12-31	96.66%

ALBO Gross Margin - Peers Comparison

Ticker	Name	Value
BCYC	Bicycle Therapeutics PLC	7775.20%
DYN	Dyne Therapeutics Inc	7775.20%
HARP	Harpoon Therapeutics Inc	7775.20%
MREO	Mereo Biopharma Group PLC	74.26%
VRTX	Vertex Pharmaceuticals Inc	86.11%
950200.KQ	Psomagen Inc	23.13%
ABBV	Abbvie Inc	69.99%
ALDX	Aldeyra Therapeutics Inc	7775.20%
ISEE	IVERIC bio Inc	7775.20%
VXRT	Vaxart Inc	100.00%
AMGN	Amgen Inc	68.71%
DTIL	Precision BioSciences Inc	7775.20%
EVLO	Evelo Biosciences Inc	7775.20%
MTEM	Molecular Templates Inc	7775.20%
OYST	Oyster Point Pharma Inc	93.79%
SLDB	Solid Biosciences Inc	7775.20%
ARDX	Ardelyx Inc	84.85%
IDYA	IDEAYA Biosciences Inc	7775.20%
INZY	Inozyme Pharma Inc	7775.20%
APLT	Applied Therapeutics Inc	7775.20%
MRNA	Moderna Inc	70.06%
CRNX	Crinetics Pharmaceuticals Inc	7775.20%
GERN	Geron Corp	98.37%
PSTX	Poseida Therapeutics Inc	7775.20%
SYRS	Syros Pharmaceuticals Inc	7775.20%
AVRO	AVROBIO Inc	7775.20%
KALV	Kalvista Pharmaceuticals Inc	7775.20%
RAPT	Rapt Therapeutics Inc	7775.20%
KDNY	Chinook Therapeutics Inc	7775.20%
MGTA	Magenta Therapeutics Inc	7775.20%
MIRM	Mirum Pharmaceuticals Inc	75.77%
REGN	Regeneron Pharmaceuticals Inc	87.01%
950160.KQ	Kolon TissueGene Inc	11.72%
950220.KQ	Neoimmunetech Inc	7775.20%
GILD	Gilead Sciences Inc	78.26%